Study of thermal conductivity of nanofluids for the application of heat transfer fluids
DH Yoo, KS Hong, HS Yang - Thermochimica Acta, 2007 - Elsevier
TiO 2 , Al 2 O 3 , Fe, and WO 3 nanofluids are prepared in a two-step procedure by dispersing
nanoparticles in a basefluid. Since nanoparticles form clusters in fluids, a cell disrupter …
nanoparticles in a basefluid. Since nanoparticles form clusters in fluids, a cell disrupter …
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when …
DH Yoo, P Hrycaj, P Miranda, E Ramiterre… - Annals of the …, 2013 - ard.bmj.com
Objectives To compare the efficacy and safety of innovator infliximab (INX) and CT-P13, an
INX biosimilar, in active rheumatoid arthritis patients with inadequate response to …
INX biosimilar, in active rheumatoid arthritis patients with inadequate response to …
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in …
…, MJ Lim, YA Lee, SJ Lee, HU Kim, DH Yoo… - Annals of the …, 2013 - ard.bmj.com
… Dae Hyun Yoo12, … Dae Hyun Yoo Pawel Hrycaj Pedro Miranda Edgar Ramiterre Mariusz
Piotrowski Sergii Shevchuk Volodymyr Kovalenko Nenad Prodanovic Mauricio Abello-Banfi …
Piotrowski Sergii Shevchuk Volodymyr Kovalenko Nenad Prodanovic Mauricio Abello-Banfi …
A novel non-intrusive eye gaze estimation using cross-ratio under large head motion
Eye gaze estimation systems calculate the direction of human eye gaze. Numerous accurate
eye gaze estimation systems considering a user’s head movement have been reported. …
eye gaze estimation systems considering a user’s head movement have been reported. …
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week …
DH Yoo, A Racewicz, J Brzezicki, R Yatsyshyn… - Arthritis research & …, 2016 - Springer
Background CT-P13 (Remsima®, Inflectra®) is a biosimilar of the infliximab reference
product (RP; Remicade®). The aim of this study was to compare the 54-week efficacy, …
product (RP; Remicade®). The aim of this study was to compare the 54-week efficacy, …
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and …
DH Yoo, N Prodanovic, J Jaworski, P Miranda… - Annals of the …, 2017 - ard.bmj.com
Objectives To assess the efficacy and safety of switching from the infliximab reference
product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing CT-P13 in …
product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing CT-P13 in …
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a …
…, YM Kang, SR Kwon, SH Lee, SS Lee, DH Yoo… - The Lancet, 2017 - thelancet.com
Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative …
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative …
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus
Objective To determine the cytotoxicity of natural killer (NK) cells and the level of differentiation
of hematopoietic stem cells (HSCs) into NK cells in systemic lupus erythematosus (SLE). …
of hematopoietic stem cells (HSCs) into NK cells in systemic lupus erythematosus (SLE). …
Animal-assisted and pet-robot interventions for ameliorating behavioral and psychological symptoms of dementia: a systematic review and meta-analysis
Patients with dementia suffer from psychological symptoms such as depression, agitation,
and aggression. One purpose of dementia intervention is to manage patients’ inappropriate …
and aggression. One purpose of dementia intervention is to manage patients’ inappropriate …
Gut microbiota-mediated drug interactions between lovastatin and antibiotics
DH Yoo, IS Kim, TK Van Le, IH Jung, HH Yoo… - Drug Metabolism and …, 2014 - ASPET
… Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun
Kim … Wrote or contributed to the writing of the manuscript: DH Yoo, DH Kim, HH Yoo. …
Kim … Wrote or contributed to the writing of the manuscript: DH Yoo, DH Kim, HH Yoo. …
